BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29449055)

  • 1. Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates.
    Shvartzman Y; Krivoy A; Valevski A; Gur S; Weizman A; Hochman E
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):353-360. PubMed ID: 29449055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study.
    Hochman E; Krivoy A; Schaffer A; Weizman A; Valevski A
    Bipolar Disord; 2016 Dec; 18(8):684-691. PubMed ID: 27933713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Goldberg JF; Perlis RH; Ghaemi SN; Calabrese JR; Bowden CL; Wisniewski S; Miklowitz DJ; Sachs GS; Thase ME
    Am J Psychiatry; 2007 Sep; 164(9):1348-55. PubMed ID: 17728419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care setting.
    Sussman M; Friedman M; Korn JR; Hassan M; Kim J; Menzin J
    J Affect Disord; 2012 May; 138(3):425-32. PubMed ID: 22326843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid personality disorders in manic bipolar I disorder patients is associated with increased use of long-acting injectable antipsychotic treatment and higher rates of rehospitalization.
    Goren Y; Krivoy A; Gur S; Valevski A; Weizman A; Hochman E
    Int Clin Psychopharmacol; 2020 Mar; 35(2):74-80. PubMed ID: 31764217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does recent mania affect response to antidepressants in bipolar disorder? A re-analysis of STEP-BD data.
    Mousavi Z; Johnson S; Li D
    J Affect Disord; 2018 Aug; 236():136-139. PubMed ID: 29734096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
    Niu X; Dennen S; Dembek C; Laubmeier K; Liu Y; Veeranki P; Tocco M; Williams GR
    Curr Ther Res Clin Exp; 2021; 94():100629. PubMed ID: 34306269
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders.
    Chang JS; Ha KS; Young Lee K; Sik Kim Y; Min Ahn Y
    J Clin Psychiatry; 2006 Mar; 67(3):461-7. PubMed ID: 16649834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
    Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
    J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics.
    Um YH; Kim TW; Seo HJ; Hong SC; Kim SM; Oh JH; Jeong JH
    Int Clin Psychopharmacol; 2020 Sep; 35(5):263-269. PubMed ID: 32459726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
    Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
    JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial.
    Vöhringer PA; Ostacher MJ; El-Mallakh RS; Holtzman NS; Thommi SB; Whitham EA; Sullivan MC; Baldassano CF; Goodwin FK; Baldessarini RJ; Ghaemi SN
    J Clin Psychopharmacol; 2015 Oct; 35(5):605-8. PubMed ID: 26267418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.
    Mandelli L; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
    Adv Ther; 2017 Mar; 34(3):713-724. PubMed ID: 28144920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Use of Mood Stabilizers With Antidepressants in Asia: Report From the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Projects in 2004 and 2013.
    Rajaratnam K; Xiang YT; Tripathi A; Chiu HF; Si TM; Chee KY; Avasthi A; Grover S; Chong MY; Kuga H; Kanba S; He YL; Lee MS; Yang SY; Udomratn P; Kallivayalil RA; Tanra AJ; Maramis MM; Shen WW; Sartorius N; Kua EH; Tan CH; Mahendran R; Shinfuku N; Sum MY; Baldessarini RJ; Sim K
    J Clin Psychopharmacol; 2017 Apr; 37(2):255-259. PubMed ID: 28146001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.